(1)
Development and Validation of the Competing Risk Nomogram and Risk Classification System for Predicting Cancer-Specific Mortality in Patients With Cervical Adenosquamous Carcinoma Treated via Radical Hysterectomy. Biomol Biomed 2025, 25 (5), 1099–1110. https://doi.org/10.17305/bb.2024.11217.